Lung cancer is one of the most common types of cancer in the UK, according to the NHS, with almost 45,000 people diagnosed with the condition every year in the UK.
The outlook for lung cancer patients isn’t as good as many other types of cancer, with one in three patients living for at least a year after their initial diagnosis.
Sativa (LON:SATI) seeks to invest in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.